Brain Tissue Specimen Collection

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00593203
First received: January 2, 2008
Last updated: NA
Last verified: January 2008
History: No changes posted
  Purpose

The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures. Leftover tissue removed during the course of brain surgery will be collected and stored in neurosurgical laboratories for use in medical research that might be currently ongoing or for future research. In addition, blood and cerebral spinal fluid samples will also be collected and stored. Leftover cerebral spinal fluid (CSF) will be collected during standard of care procedures (lumbar punctures or ventricular drains) that take place at time of diagnosis, completion of therapy and relapse of disease or during neurosurgery. Blood will be drawn at time of routine lab draws required during the surgery or procedure.


Condition
Brain Diseases

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Molecular Neurosurgical Tissue Bank

Resource links provided by NLM:


Further study details as provided by Vanderbilt University:

Biospecimen Retention:   Samples With DNA

Brain Tissue, blood and cerebral spinal fluid


Estimated Enrollment: 500
Study Start Date: May 2003
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

infant through Adults

Criteria

Inclusion Criteria:

  • Subjects having any type of brain surgery, where a specimen will be collected.

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00593203

Locations
United States, Tennessee
Vanderbilt University Medical Center, Deptartment of Neurological Surgery
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Reid C. Thompson, M.D. Vanderbilt University Medical Center, Department of Neurological Surgery
  More Information

No publications provided

Responsible Party: Reid C. Thompson, M.D., Vanderbilt University Neurological Surgery
ClinicalTrials.gov Identifier: NCT00593203     History of Changes
Other Study ID Numbers: 030372
Study First Received: January 2, 2008
Last Updated: January 2, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 29, 2014